Pharmaceuticals News and Research

RSS

Skinvisible obtains Korean patent for polymer delivery system

Skinvisible, Inc. announced today that the South Korean patent office has granted a patent for Invisicare®, the company's polymer delivery system for topical dermatology products.

24 Mar 2010

Shingles drug receives clearance for final stage of testing

A new Welsh-developed drug to help alleviate the suffering of shingles could move a step closer for patients if the final stage of testing is given the go-ahead.

24 Mar 2010

New legislation will improve consumers' safety, says Pew Charitable Trusts

Allan Coukell, director of the Pew Prescription Project, issued the following statement today, commending Congress for including provisions from the Physician Payments Sunshine Act in health care reform legislation.

24 Mar 2010

Pharmaceutical firms, GAVI Alliance agree to provide long-term supply of Pneumococcal vaccine

Millions of infants and young children in the world's poorest countries will receive potentially life-saving vaccines that help protect against pneumococcal disease, including pneumonia -- the world's biggest childhood killer, thanks to new agreements made with two major pharmaceutical firms, the GAVI Alliance announced today.

24 Mar 2010

Vaccine deal signed - 47 developing countries to receive low priced vaccines by 2015

Pharmaceutical giants have signed a historical 10-year deal on Tuesday pledging the supply of 60 million doses a year of pneumococcal vaccines at cut-prices to developing nations.

24 Mar 2010

AHF to protest against Merck's pricing of Isentress

AIDS Healthcare Foundation will host a protest Wednesday morning, March 24th at 10:30am targeting Merck and Co. Pharmaceuticals over the pricing and policies for its key HIV/AIDS drug, Isentress, one of the most expensive first-line AIDS treatment in the US, during the Barclays Capital Global Healthcare Conference.

24 Mar 2010

China Biologic Products' fourth quarter revenue rises 185.6%

China Biologic Products, Inc., one of the leading plasma-based biopharmaceutical companies in the People's Republic of China, operating through its indirect majority-owned subsidiaries, Shandong Taibang Biological Products Co. Ltd and Guiyang Dalin Biologic Technologies Co., Ltd. and its equity investment in Xi'an Huitian Blood Products Co., Ltd., today reported financial results for the fourth quarter and year ended December 31, 2009.

24 Mar 2010

Cegedim Dendrite's Sample Management Solutions launched in Europe CE

Cegedim Dendrite, the world’s leading provider of Pharmaceutical and Life-Sciences CRM solutions, today announced the launch of Sample Management Solutions, a new offering in Europe designed to help biopharmaceuticals companies comply with legal requirements associated with sample distribution.

24 Mar 2010

Bioalliance Pharma's anti-emetic drug Setofilm receives European approval

BioAlliance Pharma SA, a company dedicated to the treatment and supportive care of cancer and AIDS patients, today announced approval for Setofilm® in 16 European countries.

24 Mar 2010

Renowned leaders to discuss latest findings in early-stage drug development for cancer

When people think of cancer treatment, chemotherapy infusions, injections and pills often come to mind. These treatments result from extensive research and testing in drug development. But how does the process begin?

24 Mar 2010

Portola Pharmaceuticals commences Phase 1 trial of PRT062607 for chronic inflammatory diseases

Portola Pharmaceuticals, Inc. today announced that it has initiated its first in human Phase 1 trial in healthy volunteers of PRT062607, a novel, oral Syk-specific kinase inhibitor in development to treat chronic inflammatory diseases, including rheumatoid arthritis (RA), and certain cancers, including non-Hodgkin's lymphoma and chronic lymphocytic leukemia. In preclinical in vivo models of RA, PRT062607 was shown to reduce inflammation in a dose-dependent manner.

23 Mar 2010

Alnylam Pharmaceuticals earns $20M technology transfer payment from Takeda Pharmaceutical

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, today announced that it has earned a $20 million technology transfer payment from Takeda Pharmaceutical Company Limited as part of the strategic alliance the companies formed in May 2008.

23 Mar 2010

Merix Pharmaceutical introduces new Fast-Results! Genital Herpes Treatment

Merix Pharmaceutical Corp. unveiled its new Fast-Results!™ Genital Herpes Treatment March 1st while attending a retail industry trade show in Dallas. The first ever OTC treatment for genital herpes, Fast-Results! answers the unmet need of people who suffer painful symptoms caused by the herpes virus.

23 Mar 2010

BioSante Pharmaceuticals receives FDA Orphan Drug designation for GVAX AML Vaccine

BioSante Pharmaceuticals, Inc. today announced positive GVAX AML Vaccine results and BioSante’s receipt of Orphan Drug designation from the FDA’s Office of Orphan Products Development for GVAX AML Vaccine in the treatment of acute myeloid leukemia. This Orphan Drug designation is the second GVAX cancer vaccine from BioSante to secure FDA orphan drug designation.

23 Mar 2010

Report shows growth of the U.S. market for vascular access devices and accessories

According to a new global report series by iData Research, the leading authority in medical device, dental and pharmaceutical market research, the U.S. market for vascular access devices and accessories was valued at just over $3 billion in 2009 and is estimated to reach over $4.6 billion by 2016.

23 Mar 2010

Aradigm reports net loss of $3.4M for fourth-quarter 2009

Aradigm Corporation today announced financial results for the fourth quarter and full year ended December 31, 2009.

23 Mar 2010

WebIQ Pharma survey solution launched for pharmaceutical industry

Usability Sciences Corporation launches its WebIQ Pharma offering, an intelligent survey solution that provides pharmaceutical sites with metrics to answer critical questions about site and content effectiveness, to increase return on investment. Usability Sciences has provided usability and user experience research to Merck, Eli Lilly, Novartis and Ortho McNeil for over ten years.

23 Mar 2010

Itamar Medical's EndoPAT systems in use around the world to diagnose cardiovascular disease

At the 2010 ACC conference held in Atlanta, GA, six new studies based on the PAT™ (Peripheral Arterial Tone) signal focused on assessing cardiovascular risk by measuring and improving endothelial health. Of those, two studies from Japan focused on assessing cardiovascular risk in both high and low risk patient populations.

23 Mar 2010

Investment report on Arrowhead Research

BeaconEquity.com announces an investment report featuring Arrowhead Research Corp. The report includes financial, comparative and investment analyses, and pertinent industry information you need to know to make an educated investment decision.

23 Mar 2010

Pfizer's Neurontin to earn 50% patient share in treatment of postherpetic neuralgia: Survey

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that a novel formulation of Pfizer's Neurontin that is dosed once a day would earn a 50 percent patient share in the treatment of postherpetic neuralgia, according to surveyed U.S. neurologists.

23 Mar 2010

Pharmaceuticals News and Research

Skinvisible obtains Korean patent for polymer delivery system

Shingles drug receives clearance for final stage of testing

New legislation will improve consumers' safety, says Pew Charitable Trusts

Pharmaceutical firms, GAVI Alliance agree to provide long-term supply of Pneumococcal vaccine

Vaccine deal signed - 47 developing countries to receive low priced vaccines by 2015

AHF to protest against Merck's pricing of Isentress

China Biologic Products' fourth quarter revenue rises 185.6%

Cegedim Dendrite's Sample Management Solutions launched in Europe CE

Bioalliance Pharma's anti-emetic drug Setofilm receives European approval

Renowned leaders to discuss latest findings in early-stage drug development for cancer

Portola Pharmaceuticals commences Phase 1 trial of PRT062607 for chronic inflammatory diseases

Alnylam Pharmaceuticals earns $20M technology transfer payment from Takeda Pharmaceutical

Merix Pharmaceutical introduces new Fast-Results! Genital Herpes Treatment

BioSante Pharmaceuticals receives FDA Orphan Drug designation for GVAX AML Vaccine

Report shows growth of the U.S. market for vascular access devices and accessories

Aradigm reports net loss of $3.4M for fourth-quarter 2009

WebIQ Pharma survey solution launched for pharmaceutical industry

Itamar Medical's EndoPAT systems in use around the world to diagnose cardiovascular disease

Investment report on Arrowhead Research

Pfizer's Neurontin to earn 50% patient share in treatment of postherpetic neuralgia: Survey

Industry Focus - Biopharma eBook

Latest eBooks

A practical guide to lipid nanoparticle formulation and resizing

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence